Stewart is an experienced Seattle biotech executive. She has served as CEO of the Infectious Disease Research Institute (IDRI) and remains on their Board. Stewart founded Targeted Genetics Corporation (Nasdaq: TGEN) in 1992, a Seattle-based biotechnology company formed to develop gene-based treatments for acquired and inherited disease. She held the position of President and CEO from the company’s inception until November of 2008. Prior to founding Targeted Genetics, Stewart held various positions at Immunex Corp. from 1981-1992, ending her tenure there as VP of Corporate Development. Stewart currently serves as a member of the Board of Directors for several for-profit and non-profit institutions, including the WBBA. Ms. Parker received her B.A. and M.B.A. from the University of Washington.